Health Care & Life Sciences » Pharmaceuticals | Sumitomo Dainippon Pharma Co. Ltd.

Sumitomo Dainippon Pharma Co. Ltd.

Sumitomo Dainippon Pharma Co. Ltd.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
397.9 M
Public Float
-
Sumitomo Dainippon Pharma Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY122.4
Market Cap
JPY835.51 B
Shares Outstanding
397.9 M
Public Float
129.95 M

Profile

Address
2-6-8 Dosho-machi
Osaka Osaka 541
Japan
Employees -
Website http://www.ds-pharma.co.jp
Updated 07/08/2019
Sumitomo Dainippon Pharma Co., Ltd. engages in manufacturing, sale, import and export of pharmaceuticals products. It operates through the Pharmaceutical Business and Other Business segments. The Pharmaceutical Business segment handles the creation of new pharmaceutical products.

Financials

View All
Created with Highcharts 5.0.14Sumitomo Dainippon Pharma Co. Ltd.Net Income. Fiscal year is April-March. All values JPY Millions.20 06020 06015 44715 44724 69724 69731 31631 31653 44853 44848 62748 627201420152016201720182019010k20k30k40k50k60k
Created with Highcharts 5.0.14Sumitomo Dainippon Pharma Co. Ltd.Sales/Revenue. Fiscal year is April-March. All values JPY Millions.387 693387 693371 370371 370403 206403 206408 357408 357466 838466 838459 267459 2672014201520162017201820190100k200k300k400k500k

Masayo Tada
Chairman
Hiroshi Nomura
President, Chief Executive Officer & Director